121 related articles for article (PubMed ID: 2647292)
21. [A study of amplifications of myc gene (c-myc and N-myc) in human ovarian cancer].
Kataoka A; Yakushiji M; Kojiro M
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Mar; 42(3):259-63. PubMed ID: 2332674
[TBL] [Abstract][Full Text] [Related]
22. Incidence of activating ras oncogene mutations associated with primary and metastatic human breast cancer.
Rochlitz CF; Scott GK; Dodson JM; Liu E; Dollbaum C; Smith HS; Benz CC
Cancer Res; 1989 Jan; 49(2):357-60. PubMed ID: 2642738
[TBL] [Abstract][Full Text] [Related]
23. Point mutations of the c-Ki-ras gene in carcinoma and atypical epithelium associated with congenital biliary dilation.
Tomono H; Nimura Y; Aono K; Nakashima I; Iwamoto T; Nakashima N
Am J Gastroenterol; 1996 Jun; 91(6):1211-4. PubMed ID: 8651173
[TBL] [Abstract][Full Text] [Related]
24. Detection of mutated c-Ki-ras in the bile of patients with pancreatic cancer.
Abbruzzese JL; Evans DB; Raijman I; Larry L; King T; Leach SD; Frazier ML
Anticancer Res; 1997; 17(2A):795-801. PubMed ID: 9137410
[TBL] [Abstract][Full Text] [Related]
25. K-ras mutations in nonmucinous ovarian epithelial tumors: a molecular analysis and clinicopathologic study of 144 patients.
Cuatrecasas M; Erill N; Musulen E; Costa I; Matias-Guiu X; Prat J
Cancer; 1998 Mar; 82(6):1088-95. PubMed ID: 9506354
[TBL] [Abstract][Full Text] [Related]
26. Evidence against ras activation in human ovarian carcinomas.
Haas M; Isakov J; Howell SB
Mol Biol Med; 1987 Oct; 4(5):265-75. PubMed ID: 3320675
[TBL] [Abstract][Full Text] [Related]
27. Mutations of the Ki-ras oncogene in carcinoma of the endometrium.
Caduff RF; Johnston CM; Frank TS
Am J Pathol; 1995 Jan; 146(1):182-8. PubMed ID: 7856726
[TBL] [Abstract][Full Text] [Related]
28. Amplifications of both c-Ki-ras with a point mutation and c-myc in a primary pancreatic cancer and its metastatic tumors in lymph nodes.
Yamada H; Sakamoto H; Taira M; Nishimura S; Shimosato Y; Terada M; Sugimura T
Jpn J Cancer Res; 1986 Apr; 77(4):370-5. PubMed ID: 3009377
[TBL] [Abstract][Full Text] [Related]
29. Analysis of Ki-ras gene mutations within the same tumor using a single tumor crypt in colorectal carcinomas.
Ishii M; Sugai T; Habano W; Nakamura S
J Gastroenterol; 2004 Jun; 39(6):544-9. PubMed ID: 15235871
[TBL] [Abstract][Full Text] [Related]
30. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
[TBL] [Abstract][Full Text] [Related]
31. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
[TBL] [Abstract][Full Text] [Related]
32. Amplification and enhanced expression of cellular oncogene c-Ki-ras-2 in a human epidermoid carcinoma of the lung.
Miyaki M; Sato C; Matsui T; Koike M; Mori T; Kosaki G; Takai S; Tonomura A; Tsuchida N
Jpn J Cancer Res; 1985 Apr; 76(4):260-5. PubMed ID: 3924699
[TBL] [Abstract][Full Text] [Related]
33. KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants.
Mayr D; Hirschmann A; Löhrs U; Diebold J
Gynecol Oncol; 2006 Dec; 103(3):883-7. PubMed ID: 16806438
[TBL] [Abstract][Full Text] [Related]
34. Frequency of Ki-ras mutations and DNA alkylation in colorectal tissue from individuals living in Manchester.
Jackson PE; Hall CN; Badawi AF; O'Connor PJ; Cooper DP; Povey AC
Mol Carcinog; 1996 May; 16(1):12-9. PubMed ID: 8634090
[TBL] [Abstract][Full Text] [Related]
35. Chromosome 11q13, c-erbB-2, and c-myc amplification in invasive breast carcinoma: clinicopathologic correlations.
Gaffey MJ; Frierson HF; Williams ME
Mod Pathol; 1993 Nov; 6(6):654-9. PubMed ID: 7905628
[TBL] [Abstract][Full Text] [Related]
36. Gene amplification in gastric and esophageal adenocarcinomas.
Houldsworth J; Cordon-Cardo C; Ladanyi M; Kelsen DP; Chaganti RS
Cancer Res; 1990 Oct; 50(19):6417-22. PubMed ID: 2400999
[TBL] [Abstract][Full Text] [Related]
37. Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy.
Mok SC; Bell DA; Knapp RC; Fishbaugh PM; Welch WR; Muto MG; Berkowitz RS; Tsao SW
Cancer Res; 1993 Apr; 53(7):1489-92. PubMed ID: 8384077
[TBL] [Abstract][Full Text] [Related]
38. Amplification of the c-myc proto-oncogene in human chondrosarcoma.
Castresana JS; Barrios C; Gómez L; Kreicbergs A
Diagn Mol Pathol; 1992 Dec; 1(4):235-8. PubMed ID: 1342971
[TBL] [Abstract][Full Text] [Related]
39. Identification of mutations in the Ki-ras gene in human retinoblastoma.
Bautista D; Emanuel JR; Granville C; Howard R; Costa J
Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2313-7. PubMed ID: 8843915
[TBL] [Abstract][Full Text] [Related]
40. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.
Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T
Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
